Novorapid and Hypokalaemic syndrome - from FDA reports


Summary

Hypokalaemic syndrome is found among people who take Novorapid, especially for people who are female, 60+ old , have been taking the drug for < 1 month, also take medication Lantus, and have Type 2 diabetes. This review analyzes which people have Hypokalaemic syndrome with Novorapid. It is created by eHealthMe based on reports of 10,541 people who have side effects when taking Novorapid from FDA , and is updated regularly.

What to expect?

If you take Novorapid and have Hypokalaemic syndrome, find out what symptoms you could have in 1 year or longer.

You are not alone!

Join a support group for people who take Novorapid and have Hypokalaemic syndrome

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA since 1977. Our tools are simple to use, anonymous and free. Start now >>>

On Jan, 18, 2018

10,541 people reported to have side effects when taking Novorapid.
Among them, 74 people (0.7%) have Hypokalaemic syndrome


Number of reports submitted per year:

Could Novorapid cause Hypokalaemic syndrome?

Time on Novorapid when people have Hypokalaemic syndrome *:

  • < 1 month: 77.78 %
  • 1 - 6 months: 0.0 %
  • 6 - 12 months: 22.22 %
  • 1 - 2 years: 0.0 %
  • 2 - 5 years: 0.0 %
  • 5 - 10 years: 0.0 %
  • 10+ years: 0.0 %

Gender of people who have Hypokalaemic syndrome when taking Novorapid *:

  • female: 60.81 %
  • male: 39.19 %

Age of people who have Hypokalaemic syndrome when taking Novorapid *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 8.57 %
  • 20-29: 2.86 %
  • 30-39: 4.29 %
  • 40-49: 4.29 %
  • 50-59: 24.29 %
  • 60+: 55.71 %

Top conditions involved for these people *:

  • Type 2 Diabetes (13 people, 17.57%)
  • High Blood Pressure (9 people, 12.16%)
  • Pain (7 people, 9.46%)
  • Preventive Health Care (5 people, 6.76%)
  • Acute Lymphocytic Leukemia (all) (4 people, 5.41%)

Top co-used drugs for these people *:

  • Lantus (26 people, 35.14%)
  • Slow-K (15 people, 20.27%)
  • Aldactone (11 people, 14.86%)
  • Lasix (10 people, 13.51%)
  • Levemir (9 people, 12.16%)

Top other side effects for these people *:

  • Hypoglycemia (15 people, 20.27%)
  • Malaise (9 people, 12.16%)
  • Interstitial Lung Disease (7 people, 9.46%)
  • Blood Creatinine Increased (7 people, 9.46%)
  • Anaemia (7 people, 9.46%)

* Approximation only. Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Subscribe to the study: get notified of updates to the study.

Want to find out more about the FDA reports used in the study? You can request them from FDA.

Do you have Hypokalaemic syndrome when taking Novorapid?

Expand the study to include all drugs with the same ingredients

Hypokalaemic syndrome and drugs with ingredients of insulin aspart recombinant.

Expand the study to include reports from both FDA and eHealthMe

Hypokalaemic syndrome and Novorapid from FDA and eHealthMe reports

Novorapid

Novorapid has active ingredients of insulin aspart recombinant. It is often used in type 1 diabetes. (latest outcomes from Novorapid 10,637 users)

Hypokalaemic syndrome

Hypokalaemic syndrome (serum concentration of potassium <3.5) has been reported by people with high blood pressure, osteoporosis, pain, depression, multiple myeloma (latest reports from 36,203 Hypokalaemic syndrome patients).

Browse all side effects of Novorapid

a b c d e f g h i j k l m n o p q r s t u v w x y z

Drugs that are associated with Hypokalaemic syndrome

Hypokalaemic syndrome

Could your condition cause Hypokalaemic syndrome

Hypokalaemic syndrome

Related studies

What would happen?

Forecast new side effects and undetected conditions when you take Novorapid and have Hypokalaemic syndrome.

Questions to the study

More questions >

User posts to the study

More posts >